In this week’s View, Dr. Eagle discusses the development and validation of the American Heart Association’s PREVENT risk assessment tool. He then explores implantable hemodynamic monitors and their role in improving survival in patients with heart failure and reduced ejection fraction. Finally, Dr. Eagle talks about the 10-year outcomes of the NOTION trial regarding transcatheter or surgical aortic valve implantation. 

Subscribe to Eagle’s Eye View